Usually Glycine Insulin and Repaglinide can be used together to lower blood sugar, but need to be used together under the guidance of a doctor. Patients with type 2 diabetes are suffering from elevated venous blood glucose due to relative insufficiency of insulin secretion in the body, and diabetes treatment chooses medication to control blood glucose. Usually, when medication does not control blood glucose satisfactorily, subcutaneous glucose-lowering treatment with insulin injections can be considered. If necessary, oral hypoglycemic drugs plus insulin combined hypoglycemic treatment. Repaglinide is a non-sulfonylurea oral hypoglycemic drug, the mechanism is to promote the release of insulin from the pancreas to lower glucose treatment. Glucagon belongs to the basal insulin class, which is usually effective in lowering glucose smoothly, and is injected subcutaneously once a day for glucose-lowering treatment. The combination of the two is suitable for people who have poor glycemic control when treated with only one type of glucose-lowering drug. Usually, the combination of insulin and glargine can be used to lower blood glucose. It is recommended to consult an endocrinologist and take the relevant medication under the doctor’s guidance. If the blood glucose control is not stable, timely follow-up is needed.